NASDAQ:CBAY - CymaBay Therapeutics Price Target & Analyst Ratings

+0.28 (+4.46 %)
(As of 06/18/2019 01:31 AM ET)
Today's Range
Now: $6.56
50-Day Range
MA: $11.63
52-Week Range
Now: $6.56
Volume1.36 million shs
Average Volume993,571 shs
Market Capitalization$450.63 million
P/E RatioN/A
Dividend YieldN/A

Analyst Ratings

CymaBay Therapeutics (NASDAQ:CBAY) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
10 Wall Street analysts have issued ratings and price targets for CymaBay Therapeutics in the last 12 months. Their average twelve-month price target is $13.8750, suggesting that the stock has a possible upside of 111.51%. The high price target for CBAY is $22.00 and the low price target for CBAY is $7.00. There are currently 1 hold rating and 9 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.902.902.893.00
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $13.8750$20.1250$20.2857$21.75
Price Target Upside: 111.51% upside62.82% upside59.86% upside152.91% upside

CymaBay Therapeutics (NASDAQ:CBAY) Consensus Price Target History

Price Target History for CymaBay Therapeutics (NASDAQ:CBAY)

CymaBay Therapeutics (NASDAQ:CBAY) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/17/2019B. RileySet Price TargetHold$7.00LowView Rating Details
6/13/2019CitigroupLower Price TargetBuy$21.00 ➝ $12.00HighView Rating Details
6/12/2019HC WainwrightReiterated RatingBuy$24.00 ➝ $12.00LowView Rating Details
6/11/2019OppenheimerSet Price TargetBuy$12.00HighView Rating Details
6/11/2019Piper Jaffray CompaniesLower Price TargetOverweight ➝ Buy$30.00 ➝ $8.00HighView Rating Details
4/23/2019Raymond JamesSet Price TargetBuy$18.00LowView Rating Details
4/14/2019Cantor FitzgeraldSet Price TargetBuy$20.00MediumView Rating Details
2/22/2019Leerink SwannInitiated CoverageOutperform$22.00HighView Rating Details
2/21/2019Svb LeerinkReiterated RatingOutperformMediumView Rating Details
2/19/2019Roth CapitalReiterated RatingBuyLowView Rating Details
3/16/2018SunTrust BanksReiterated RatingBuy$19.00HighView Rating Details
2/13/2018Evercore ISIInitiated CoverageOutperform ➝ OutperformHighView Rating Details
8/11/2017Ifs SecuritiesDowngradeStrong-Buy ➝ OutperformHighView Rating Details
7/20/2017CIBCReiterated RatingOutperform ➝ Outperform$8.00 ➝ $15.00MediumView Rating Details
(Data available from 6/18/2017 forward)
This page was last updated on 6/18/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel